Mineralys Therapeutics, Inc.
MLYS
$25.02
-$0.71-2.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 38.60M | 31.92M | 28.36M | 25.78M | 23.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 170.60M | 184.09M | 203.07M | 201.49M | 192.40M |
| Operating Income | -170.60M | -184.09M | -203.07M | -201.49M | -192.40M |
| Income Before Tax | -154.65M | -171.36M | -190.77M | -188.51M | -177.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -154.65 | -171.36 | -190.77 | -188.51 | -177.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -154.65M | -171.36M | -190.77M | -188.51M | -177.81M |
| EBIT | -170.60M | -184.09M | -203.07M | -201.49M | -192.40M |
| EBITDA | -170.55M | -184.03M | -203.01M | -201.44M | -192.36M |
| EPS Basic | -2.38 | -2.96 | -3.57 | -3.74 | -3.64 |
| Normalized Basic EPS | -1.49 | -1.85 | -2.23 | -2.33 | -2.28 |
| EPS Diluted | -2.38 | -2.96 | -3.57 | -3.74 | -3.64 |
| Normalized Diluted EPS | -1.49 | -1.85 | -2.23 | -2.33 | -2.28 |
| Average Basic Shares Outstanding | 269.76M | 239.17M | 218.39M | 202.29M | 194.03M |
| Average Diluted Shares Outstanding | 269.76M | 239.17M | 218.39M | 202.29M | 194.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |